MoneyWorks4Me

Dr. Reddys reports consolidated net loss of Rs 538 crore in Q3

27 Jan 2020 Evaluate

Dr. Reddys Laboratories has reported results for third quarter ended December 31, 2019.

The company has reported a rise of 30.62% in its net profit at Rs 521.70 crore for the quarter under review as compared to Rs 399.40 crore for the same quarter in the previous year. Total income of the company increased by 10.22% at Rs 3113.30 crore for Q3FY20 as compared Rs 2,824.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a net loss after taxes and share of profit of associates of Rs 538.40 crore for the quarter under review against net profit of Rs 500.30 crore for the same quarter in the previous year. However, total income of the company increased by 12.54% at Rs 4464.40 crore for Q3FY20 as compared Rs 3966.90 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..